{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Brooklyn",
      "state": "NY",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "83136",
      "recalling_firm": "Infusion Options, Inc.",
      "address_1": "5924 13th Ave",
      "address_2": "N/A",
      "postal_code": "11219-4934",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "NY only",
      "recall_number": "D-1801-2019",
      "product_description": "PEMBROLIZUMAB 200 MG / 100 ML NS IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233",
      "product_quantity": "N/A",
      "reason_for_recall": "Lack of Assurance of Sterility",
      "recall_initiation_date": "20190612",
      "center_classification_date": "20190815",
      "termination_date": "20250321",
      "report_date": "20190821",
      "code_info": "All lots within expiry"
    }
  ]
}